Guggenheim Capital’s Braskem BAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-19,791
| Closed | -$175K | – | 1876 |
|
|
2023
Q4 | $175K | Sell |
19,791
-1,182
| -6% | -$9.02K | ﹤0.01% | 1813 |
|
|
2023
Q3 | $172K | Sell |
20,973
-28
| -0.1% | -$271 | ﹤0.01% | 1764 |
|
|
2023
Q2 | $245K | Buy |
21,001
+49
| +0.2% | +$464 | ﹤0.01% | 1719 |
|
|
2023
Q1 | $161K | Buy |
20,952
+269
| +1% | +$2.18K | ﹤0.01% | 1837 |
|
|
2022
Q4 | $190K | Buy |
20,683
+647
| +3% | +$7.2K | ﹤0.01% | 1818 |
|
|
2022
Q3 | $195K | Buy |
20,036
+795
| +4% | +$9.93K | ﹤0.01% | 1801 |
|
|
2022
Q2 | $275K | Buy |
19,241
+6,099
| +46% | +$104K | ﹤0.01% | 1813 |
|
|
2022
Q1 | $245K | Buy |
+13,142
| New | +$249K | ﹤0.01% | 1962 |
|
|
2021
Q2 | – | Sell |
-14,859
| Closed | -$211K | – | 2176 |
|
|
2021
Q1 | $211K | Buy |
14,859
+239
| +2% | +$2.62K | ﹤0.01% | 2071 |
|
|
2020
Q4 | $132K | Sell |
14,620
-165
| -1% | -$1.4K | ﹤0.01% | 2004 |
|
|
2020
Q3 | $110K | Sell |
14,785
-74
| -0.5% | -$636 | ﹤0.01% | 1863 |
|
|
2020
Q2 | $129K | Buy |
14,859
+137
| +0.9% | +$1.18K | ﹤0.01% | 1807 |
|
|
2020
Q1 | $98K | Buy |
+14,722
| New | +$188K | ﹤0.01% | 1747 |
|
|
2019
Q2 | – | Sell |
-44,799
| Closed | -$1.16M | – | 2107 |
|
|
2019
Q1 | $1.16M | Sell |
44,799
-4,118
| -8% | -$114K | 0.01% | 1308 |
|
|
2018
Q4 | $1.2M | Sell |
48,917
-19,382
| -28% | -$526K | 0.01% | 1305 |
|
|
2018
Q3 | $1.97M | Sell |
68,299
-32,684
| -32% | -$929K | 0.01% | 1245 |
|
|
2018
Q2 | $2.63M | Sell |
100,983
-18,857
| -16% | -$487K | 0.02% | 1084 |
|
|
2018
Q1 | $3.47M | Sell |
119,840
-18,781
| -14% | -$547K | 0.01% | 1243 |
|
|
2017
Q4 | $3.64M | Sell |
138,621
-18,369
| -12% | -$525K | 0.01% | 1222 |
|
|
2017
Q3 | $4.2M | Sell |
156,990
-98,917
| -39% | -$2.43M | 0.01% | 1172 |
|
|
2017
Q2 | $5.3M | Sell |
255,907
-23,884
| -9% | -$493K | 0.01% | 981 |
|
|
2017
Q1 | $5.69M | Sell |
279,791
-100,844
| -26% | -$2.12M | 0.02% | 945 |
|
|
2016
Q4 | $8.07M | Buy |
380,635
+257,782
| +210% | +$4.56M | 0.02% | 747 |
|
|
2016
Q3 | $1.89M | Sell |
122,853
-240,175
| -66% | -$3.15M | 0.01% | 1653 |
|
|
2016
Q2 | $4.3M | Buy |
363,028
+291,111
| +405% | +$3.62M | 0.01% | 1075 |
|
|
2016
Q1 | $928K | Sell |
71,917
-2,906
| -4% | -$37.1K | ﹤0.01% | 2101 |
|
|
2015
Q4 | $1.01M | Buy |
74,823
+15,579
| +26% | +$190K | ﹤0.01% | 2099 |
|
|
2015
Q3 | $499K | Buy |
59,244
+9,544
| +19% | +$73.7K | ﹤0.01% | 2422 |
|
|
2015
Q2 | $430K | Sell |
49,700
-205,682
| -81% | -$1.76M | ﹤0.01% | 2589 |
|
|
2015
Q1 | $1.77M | Buy |
255,382
+5,950
| +2% | +$54.4K | ﹤0.01% | 1894 |
|
|
2014
Q4 | $3.22M | Buy |
249,432
+232,793
| +1,399% | +$3.25M | 0.01% | 1381 |
|
|
2014
Q3 | $219K | Sell |
16,639
-110,954
| -87% | -$1.46M | ﹤0.01% | 2800 |
|
|
2014
Q2 | $1.64M | Buy |
127,593
+49,538
| +63% | +$686K | ﹤0.01% | 1964 |
|
|
2014
Q1 | $1.22M | Sell |
78,055
-61,712
| -44% | -$931K | ﹤0.01% | 2136 |
|
|
2013
Q4 | $2.5M | Sell |
139,767
-78,753
| -36% | -$1.37M | 0.01% | 1578 |
|
|
2013
Q3 | $3.48M | Sell |
218,520
-64,736
| -23% | -$992K | 0.01% | 1287 |
|
|
2013
Q2 | $4.21M | Buy |
+283,256
| New | +$4.43M | 0.02% | 1134 |
|
Other funds holding BAK
OCM
MPM
CSS
Guggenheim Capital's BAK Position: Q1 2024 in Review
Guggenheim Capital sold out of Braskem (BAK) in Q1 2024, closing a stake of 19,791 shares — an estimated $175K sold.
Guggenheim Capital first reported a position in BAK in Q2 2013 and held it in 37 quarters. The position peaked at $8.07M in Q4 2016. 50 funds tracked by Wall St. Rank hold BAK as of Q1 2024.
- Guggenheim Capital reported no remaining Braskem position as of Q1 2024 after selling out during the quarter.
- Guggenheim Capital sold 19,791 Braskem shares in Q1 2024, an estimated $175K.
- Guggenheim Capital first reported a position in Braskem in Q2 2013 and held it in 37 quarters.
- Guggenheim Capital's Braskem position peaked at $8.07M in Q4 2016.
- 50 funds tracked by Wall St. Rank held Braskem as of Q1 2024.
Based on Guggenheim Capital's 13F filing for Q1 2024, filed 14 May 2024.